Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)

Market Cap	16.47B
Revenue (ttm)	7.85B
Net Income (ttm)	161.20M
Shares Out	459.28M
EPS (ttm)	0.35
PE Ratio	103.89
Forward PE	59.29
Dividend	0.88 (2.44%)
Ex-Dividend Date	Feb 21, 2025

Volume	8,893,000
Average Volume	23,067,820
Open	35.53
Previous Close	36.05
Day's Range	34.72 - 36.27
52-Week Range	24.35 - 63.46
Beta	0.69
RSI	59.23
Earnings Date	Apr 26, 2025

About SHA:603882

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. The company also offers clinical research, health management, cold chain logistics, and scientific research services, as well as vitro diagnostics, big data, artificial intelligence, and forensic testing services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2006
• Employees: 11,586
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603882

Financial Performance

In 2023, SHA:603882's revenue was 8.54 billion, a decrease of -44.82% compared to the previous year's 15.48 billion. Earnings were 643.38 million, a decrease of -76.64%.